Belyaev I*, Praetorius J-P*, Medyukhina A, Figge MT (2021) Enhanced segmentation of label-free cells for automated migration and interaction tracking. Cytometry A , 1-12.
Büttner H*, Niehs SP*, Vandelannoote K, Cseresnyés Z, Dose B, Richter I, Gerst R, Figge MT, Stinear TP, Pidot SJ, Hertweck C# (2021) Bacterial endosymbionts protect beneficial soil fungus from nematode attack. Proc Natl Acad Sci U S A 118(37), e2110669118.
Campagner A, Ciucci D, Svensson CM, Figge MT, Cabitza F (2021) Ground truthing from multi-rater labeling with three-way decision and possibility theory. Inf Sci 545, 771-790.
Kästner B, Hengoju S, Svensson CM, Figge MT, Rosenbaum MA (2021) Mit Tropfenmikrofluidik zu Hochgeschwindigkeits-Biotechnologie. BIOspektrum 27(3), 260-262. (Review)
Kühne M, Lindemann H, Grune C, Schröder D, Cseresnyés Z, Godmann M, Koschella A, Figge MT, Eggeling C, Fischer D, Heinze T*, Heinzel T*; * corresponding authors (2021) Biocompatible sulfated valproic acid-coupled polysaccharide-based nanocarriers with HDAC inhibitory activity. J Control Release 329, 717-730.
Lehnert T, Prauße MTE, Hünniger K, Praetorius JP, Kurzai O, Figge MT (2021) Comparative assessment of immune evasion mechanisms in human whole-blood infection assays by a systems biology approach. PLOS One 16(4), e0249372.
Lehnert T*, Leonhardt I*, Timme S, Thomas-Rüddel D, Bloos F, Sponholz C, Kurzai O, Figge MT#, Hünniger K# (2021) Ex vivo immune profiling in patient blood enables quantification of innate immune effector functions. Sci Rep 11(1), 12039.
Muljajew I*, Huschke S*, Ramoji A, Cseresnyés Z, Hoeppener S, Nischang I, Foo W, Popp J, Figge MT, Weber C, Bauer M, Schubert US#, Press AT# (2021) Stealth effect of short polyoxazolines in graft copolymers: Minor changes of backbone end group determine liver cell-type specificity. ACS Nano 15(7), 12298-12313.
Press AT, Babic P, Hoffmann B, Müller T, Foo W, Hauswald W, Benecke J, Beretta M, Cseresnyés Z, Hoeppener S, Nischang I, Coldewey SM, Gräler MH, Bauer R, Gonnert F, Gaßler N, Wetzker R, Figge MT, Schubert US, Bauer M (2021) Targeted delivery of a phosphoinositide 3-kinase γ inhibitor to restore organ function in sepsis. EMBO Mol Med 13, e14436.
Sommerfeld O, Medyukhina A, Neugebauer S, Ghait M, Ulferts S, Lupp A, König R, Wetzker R, Schulz S, Figge MT, Bauer M, Press AT (2021) Targeting complement C5a receptor 1 for the treatment of immunosuppression in sepsis. Mol Ther 29(1), 338-346.